OverviewSuggest Edit

Neuronetics is a medical device company. It develops non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. In addition, the Company provides NeuroStar TMS Therapy (transcranial magnetic stimulation), a non-invasive form of neuromodulation.
TypePublic
Founded2003
HQMalvern, US
Websiteneurostar.com

Latest Updates

Employees (est.) (Dec 2019)235
Revenue (FY, 2019)$62.7 M(+19%)
Share Price (Sept 2020)$4.5 (+8%)
Cybersecurity ratingBMore

Key People/Management at Neuronetics

Charles E. Larsen

Charles E. Larsen

Co-Founder
Mark A. Demitrack

Mark A. Demitrack

Chief Medical Officer
Kevin Bitterman

Kevin Bitterman

Director
Mary Hailey

Mary Hailey

VP of Health Policy and Government Relations
Show more

Neuronetics Office Locations

Neuronetics has an office in Malvern
Malvern, US (HQ)
31 General Warren Blvd
Show all (1)

Neuronetics Financials and Metrics

Neuronetics Revenue

Embed Graph
View revenue for all periods
Neuronetics's revenue was reported to be $62.66 m in FY, 2019
USD

Revenue (Q2, 2020)

9.7m

Gross profit (Q2, 2020)

7.4m

Gross profit margin (Q2, 2020), %

76.2%

Net income (Q2, 2020)

(7.8m)

EBIT (Q2, 2020)

(6.9m)

Market capitalization (14-Sept-2020)

84.1m

Closing stock price (14-Sept-2020)

4.5

Cash (30-Jun-2020)

54.0m

EV

98.9m
Neuronetics's current market capitalization is $84.1 m.
Annual
USDFY, 2018FY, 2019

Revenue

52.8m62.7m

Cost of goods sold

12.4m15.4m

Gross profit

40.3m47.3m

Gross profit Margin, %

76%75%
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

13.3m13.7m12.7m16.6m16.0m11.5m9.7m

Cost of goods sold

3.2m3.0m2.8m4.2m4.2m2.8m2.3m

Gross profit

10.0m10.7m9.9m12.4m11.8m8.7m7.4m

Gross profit Margin, %

76%78%78%75%74%76%76%
Annual
USDFY, 2018FY, 2019

Cash

104.6m75.7m

Accounts Receivable

5.6m6.6m

Prepaid Expenses

1.8m1.8m

Inventories

2.4m2.8m
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

14.5m106.8m96.1m89.6m82.4m63.6m54.0m

Accounts Receivable

4.7m5.3m5.7m7.6m7.6m6.3m6.6m

Prepaid Expenses

4.3m2.1m1.6m1.1m2.0m1.8m1.1m

Inventories

2.4m2.6m2.4m2.6m2.9m2.9m3.3m
Annual
USDFY, 2018FY, 2019

Net Income

(24.1m)(29.0m)

Depreciation and Amortization

882.0k1.1m

Inventories

(435.0k)(306.0k)

Accounts Payable

606.0k299.0k
Quarterly
USDQ2, 2018

EV/EBIT

-88.1 x

EV/CFO

-34.4 x

Revenue/Employee

70.5k

Debt/Equity

-0.1 x

Debt/Assets

1.1 x

Financial Leverage

-0.1 x
Show all financial metrics

Neuronetics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Neuronetics Online and Social Media Presence

Embed Graph

Neuronetics News and Updates

Neuronetics Reports Second Quarter 2020 Financial and Operating Results

MALVERN, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial…

Neuronetics Announces Appointment of Bruce J. Shook to its Board of Directors

MALVERN, Pa., June 26, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced the appointme…

Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

MALVERN, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financia…

Neuronetics Appoints Andrew Macan As Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary

MALVERN, Pa., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced it has expande…

Neuronetics to Present at the 31st Annual Piper Jaffray Healthcare Conference

MALVERN, Pa., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Chris Tha…

Neuronetics Reports Third Quarter 2019 Financial and Operating Results

MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial…
Show more

Neuronetics Blogs

Neuronetics to Report First Quarter 2020 Financial and Operating Results and Host Conference Call

MALVERN, Pa. , April 21, 2020 (GLOBE NEWSWIRE) -- Neuronetics , Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it

Neuronetics, Inc. Adopts Limited Duration Shareholder Rights Plan

MALVERN, Pa. , April 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that its

Neuronetics, Inc. Announces Preliminary First Quarter 2020 Revenue, Corporate Restructuring, and Provides Business Update

MALVERN, Pa. , April 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics , Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced preliminary

Neuronetics Recognized as 2020 Top Neurology Device Provider

Company acknowledged on Top 10 List by MedTech Outlook Magazine MALVERN, Pa. , March 30, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who

Neuronetics, Inc. announces Chris Thatcher will step down as President and CEO

MALVERN, Pa. , March 05, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that the

Neuronetics to Report Fourth Quarter and Fiscal Year 2019 Financial and Operating Results and Host Conference Call

MALVERN, Pa. , Feb. 18, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it plans
Show more

Neuronetics Frequently Asked Questions

  • When was Neuronetics founded?

    Neuronetics was founded in 2003.

  • Who are Neuronetics key executives?

    Neuronetics's key executives are Charles E. Larsen, Mark A. Demitrack and Kevin Bitterman.

  • How many employees does Neuronetics have?

    Neuronetics has 235 employees.

  • What is Neuronetics revenue?

    Latest Neuronetics annual revenue is $62.7 m.

  • What is Neuronetics revenue per employee?

    Latest Neuronetics revenue per employee is $266.6 k.

  • Who are Neuronetics competitors?

    Competitors of Neuronetics include Tombot, After the Affair and Numina Counselling.

  • Where is Neuronetics headquarters?

    Neuronetics headquarters is located at 31 General Warren Blvd, Malvern.

  • Where are Neuronetics offices?

    Neuronetics has an office in Malvern.

  • How many offices does Neuronetics have?

    Neuronetics has 1 office.